期刊文献+

冠心病患者血清白介素-17与血管假友病因子、C-反应蛋白水平及冠脉病变程度的相关性 被引量:9

The correlation between IL-17 with serum vWF, CRP and the severity of coronary lesion in patients with coronary heart disease
暂未订购
导出
摘要 目的探讨冠心病患者血清白介素-17(IL-17)与血管假友病因子(vWF)、C-反应蛋白水平(CRP)及冠脉病变程度的相关性。方法选择2012年6~9月苏州大学附属第三医院治疗的冠心病患者65例为冠心病组,选择同期冠状动脉造影(CAG)正常或微小病变〈50%除外冠心病者25例为对照组;冠心病组分为稳定型心绞痛患者(SAP组)23例,不稳定型心绞痛患者(UAP组)14例,急性心肌梗死患者(AMI组)28例;采用酶联免疫分析法(ELISA)检测各组血清中IL-17、vWF水平,采用免疫散射比浊法检测CRP水平。采用Gensini评分系统评价冠脉病变程度;分析IL-17与vWF、CRP及Gensini评分的相关性。结果①AMI组白细胞计数[(7.93±2.86)×109/L]高于SAP组[(6.33±1.53)×109/L]、UAP组[(7.50±2.39)×109/L]及对照组[(6.50±1.39)×109/L],差异均有统计学意(P=0.027);SAP组、UAP组、AMI组Gensini评分[25.80(3.00,68.00)、25.25(4.00,116.00)、36.00(4.00,100.00)分]高于对照组[1.84(0.00,11.00)分],差异有高度统计学意义(P=0.001)。②AMI组、UAP组、SAP组患者血清IL-17、vWF及CRP水平与对照组比较,差异均有统计学意义(P〈0.01);AMI组、UAP组、SAP组间血清IL-17、vWF水平差异均有高度统计学意(P〈0.01);SAP组与对照组血清CRP水平比较,差异无统计学意义(P〉0.05)。而AMI组、UAP组CRP水平[(15.13±8.59)、(8.36±3.08)mg/L]均高于对照组[(3.67±0.43)mg/L],差异均有统计学意义(P〈0.01)。③经直线相关与回归分析,IL-17分别与vWF(r=0.610,P〈0.01)、CRP(r=0.568,P〈0.01)成正相关,IL-17与Gensini评分亦成正相关(r=0.438,P〈0.01)。结论 IL-17、vWF、CRP参与了冠心病的发生发展过程,IL-17可促进vWF、CRP产生,并与冠脉病变的严重程度相关。 Objective To investigate the correlation between IL-17 with serum vWF,CRP and the severity of coronary lesion in patients with coronary heart disease.Methods 65 patients with coronary heart disease from June 2012 to September in 2012 in the Third Affiliated Hospital of Soochow University were selected as coronary heart disease group,25 cases of normal coronary angiography(CAG) or minimal lesion <50% except for coronary heart disease were selected as control group.Coronary heart disease group was divided into SAP group(23 cases),UAP group(14 cases),AMI group(28 cases);ELISA was used to detect the serum level of IL-17,vWF;immuno-scatter turbidmetry was used to detect the serum level of CRP.Gensini points-scoring system was used to evaluate the degree of coronary artery lesions;the correlation was analyzed among the vWF,CRP,Gensini and IL-17.Results ①The count of white blood cell in AMI group [(7.93±2.86)×109/L] were higher than those in SAP group [(6.33 ±1.53)×109/L],UAP group [(7.50±2.39)×109/L] and control group [(6.50±1.39)×109/L],the differences were statistically significant(P = 0.027);Gensini scores in SAP group,UAP group,AMI group [25.80(3.00,68.00),25.25(4.00,116.00),36.00(4.00,100.00) scores] were higher than those in control group [1.84(0.00,11.00) scores],the differences were statistically significant(P = 0.001).② The differences of the serum level of IL-17,vWF,CRP in SAP group,UAP group,AMI group and control group were all statistically significant(P < 0.01);the differences of the serum level of IL-17,vWF among SAP group,UAP group,AMI group were all statistically significant(P < 0.01);the differences of CRP in SAP group and control group was not statistically significant(P > 0.05).CRP level in AMI group,UAP group [(15.13 ±8.59),(8.36 ± 3.08) mg/L] were all higher than those in control group [(3.67 ±0.43) mg/L],the differences were statistically significant< 0.01),the positive correlation was found in IL-17 and Gensini scores(r = 0.438,P < 0.01) according to the rectilinear correlation and regression analysis.Conclusion IL-17,vWF and CRP participate in the occurrence and development of coronary heart disease;IL-17 promote the production of vWF and CRP,it has closely relation with the order of severity in coronary lesion.
出处 《中国医药导报》 CAS 2013年第17期40-42,45,共4页 China Medical Herald
关键词 冠状动脉疾病 白介素-17 血管假友病因子 C-反应蛋白 内皮细胞 Coronary artery disease Interleukin-17 vWF Endothelial cells
  • 相关文献

参考文献11

  • 1陈敏生,刘世明,罗健东,等.心血管病学前沿:基础与临床[M].广州:广东科技出版社,2009:56-57.
  • 2Zhu F,Wang Q,Guo C, et al. IL-17 induces apoptosis of vascular en- dothelial cells-A potential mechanism for human acute coronary syndrome [J]. Clin Immuno1,2011,141 (2) : 152-160.
  • 3Pate! DN,King CA,Bailey SR,et al. Interleukin-17 stimulates C-re-] active protein expression in hepatocytes and smooth muscle cells vi p38 MAPK and ERK1/2-dependent NF-KB and C/EBP activation [J]t J Biol Chem, 2007,282 (37) : 27229-27238. |.
  • 4Erbel C,Chen L,Bea F,et aL Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice [J]. J Im- munol, 2009,183 ( 12 ) : 8167-8175.
  • 5Smith E, Prasad KM, Butcher M, et al. Blockade of interleukin- 17A results in reduced atherosclerosis in apolipoprotein E - deficient mice [J]. Circulation, 201 O, 121 ( 15 ) : 1746-1755.
  • 6杨辉剑,连环,田相亭,卓胜青.血浆丙二醛和高敏C-反应蛋白与急性心肌梗死的相关性研究[J].现代医院,2011,11(7):35-37. 被引量:14
  • 7Liao YH,Xia N,Zhou SF,et al. Interleukin-17A contributes to my- ocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration [J]. J Am Coil Cardiol,2012,59 (4) :420-429.
  • 8Madhur MS,Funt SA,Li L,et al. Role of interleukin 17 in inflamma- tion, atherosclerosis, and vascular function in apolipoprotein e-defi- cient mice [J]. Arterioscler Thromb Vasc Biol,2011,31 (7):1565- 1572.
  • 9黄群英,黄晓明,刘卫华,蒋小菊,潘勇翔,赵印平,莫江英,庞振瑶,张高寅,罗明晶.早发冠心病危险因素与冠状动脉病变相关性研究[J].广西医学,2012,34(9):1137-1141. 被引量:9
  • 10何东明,陆永光.炎性标志物检测对冠心病患者病情评价的临床意义[J].疑难病杂志,2012,11(4):251-253. 被引量:10

二级参考文献57

共引文献30

同被引文献93

  • 1谭利华.生脉汤加减配合西药治疗冠心病临床分析[J].辽宁中医学院学报,2006,8(3):82-82. 被引量:3
  • 2杨敏,陈广玲,陈畅,张钰,闫纯英.人参皂甙Rg1对大鼠急性心肌梗死的治疗作用[J].中西医结合心脑血管病杂志,2007,5(11):1075-1077. 被引量:26
  • 3Aspromonte N,Di Fusco SA,Latini R,et al.Natriuretic peptides in acute chest pain and acute coronary syndrome:from pathophysiology to clinical and prognostic applications.Coron Artery Dis,2013,24:33-39.
  • 4Ballantyne CM,Pitt B,Loscalzo J,et al.Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome[from the Limiting UNdertreatment of lipids in ACS with Rosuvastatin(LUNAR)Trial].Am J Cardiol,2013,111:506-509.
  • 5Chen S,Crother TR,Arditi M.Emerging role of IL-17in atherosclerosis.J Innate Immun,2010,2:325-333.
  • 6Otagiri K,Tsutsui H,Kumazaki S,et al.Early intervention with rosuvastatin decreases the lipid components of the plaque in acute coronary syndrome:analysis using integrated backscatter IVUS(ELAN study).Circ J,2011,75:633-641.
  • 7Gostiljac D,Dordevic'PB,Djuric'D,et al.The importance of defining serum MMP-9concentration in diabetics as an early marker of the rupture of atheromatous plaque in acute coronary syndrome.Acta Physiol Hung,2011,98:91-97.
  • 8Bona RD,Liuzzo G,Pedicino D,et al.Anti-inflammatory treatment of acute coronary syndromes.Curr Pharm Des,2011,17:4172-4189.
  • 9Mammen AL,Amato AA.Statin myopathy:a review of recent progress.Curr Opin Rheumatol,2010,22:644-650.
  • 10del Rosario Espinoza Mora M,Bhm M,Link A.The Th17/Treg imbalance in patients with cardiogenic shock.Clin Res Cardiol,2014,103:301-313.

引证文献9

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部